Abstract
Immunohistochemical expression of metallothioneins (MTs), a group of intracellular metal-binding proteins, is well documented in breast cancer. However, there is a paucity of information on the expression of the different MT isoforms in breast cancer tissues. The dichotomous association of MT overexpression with tumour types and progression led us to examine the role of the MT-1F mRNA isoform in breast cancer. We evaluated MT expression in 48 primary invasive ductal breast cancer tissues by immunohistochemistry, and the corresponding MT-1F mRNA expression via a semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) assay. The specificity of the RT-PCR products was confirmed by direct cycle sequencing and restriction enzyme digestion. Immunohistochemical analysis of MT revealed a significantly higher MT expression in histological grade 3 tumours as compared to grade 1 and 2 tumours (p=0.021). Similarly, MT-1F mRNA expression was found to be significantly higher in grade 3 tumours (p<0.001). The results suggest that the MT-1F isoform influences histological differentiation in invasive ductal breast cancer. The converse is also true in that the histological grade may determine the level of MT-1F expression in breast cancer.
References
Kägi JHR, Schaffer A: Biochemistry of metallothionein. Biochemistry 27: 8509-8515, 1998
Kägi JHR: Overview of metallothionein. Meth Enzymol 205: 613-626, 1991
Schwarz MA, Lazo JS, Yalowich JC, Allen WP, Whitmore M, Bergonia HA, Tzeng E, Billiar TR, Robbins PD, Lancaster JR Jr, Pitt BR: Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. Proc Natl Acad Sci USA 92: 4452-4456, 1995
Jasani B, Schmid KW: Significance of metallothionein overexpression in human tumours. Histopathology 31: 211-214, 1997
Ofner D, Maier H, Riedmann B, Bammer T, Rumer A, Winde G, Bocker W, Jasani B, Schmid KW: Immunohistochemical metallothionein expression in colorectal adenocarcinoma: correlation with tumour stage and patient survival. Virchows Arch A 425: 491-497, 1994
Giuffre G, Barresi G, Sturniolo GC, Sarnelli R, D'Inca R, Tuccari G: Immunohistochemical expression of metallothione in in normal human colorectal mucosa, in adenomas, and in adenocarcinomas and their associated metastases. Histopathology 29: 347-354, 1996
Bahnson RR, Banner BF, Ernstoff MS, Lazo JS, Cherian MG, Banerjee D, Chin JL: Immunohistochemical localization of metallothionein in transitional cell carcinoma of the bladder. J Urol 146: 1518-1520, 1991
Schmid KW, Ellis IO, Gee JM, Darke BM, Lees WE, Kay J, Cryer A, Stark JM, Hittmair A, Ofner D, Margreiter R, Daxenhichler G, Nicholson RI, Bier B, Bocker W, Jasani B: Presence and possible significance of immunocytochemically demonstrable metallothionein overexpression in primary invasive ductal carcinoma of the breast. Virchows Arch A 422: 153-159, 1993
Haerslev T, Jacobsen K, Nedergaard L, Zedeler K: Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph node metastases. Path Res Pract 190: 675-681, 1994
Haerslev T, Jacobsen K, Zedeler K: The prognostic significance of immunocytochemically detectable metallothionein in primary breast carcinomas. Acta Path Microbiol Immunol Scand 103: 279-285, 1995
Lim K, Evans A, Adams M, Fish R, Dhundee J, Dallimore N, Jasani B: Association of immunohistochemically detectable metallothionein (IDMT) expression with malignant transformation in cervical neoplasia. J Pathol 178 (suppl.): 48A, 1996
McCluggage WG, Maxwell P, Hamilton PW, Jasani B: High metallothione in expression is associated with features predictive of aggressive behaviour in endometrial carcinoma. Histopathology 34: 51-55, 1999
Ohshio G, Imamura T, Okada N, Wang ZH, Yamaki K, Kyogoku T, Suwa H, Yamabe H, Imamura M: Immunohistochemical study of metallothionein in pancreatic carcinomas. J Cancer Res Clin Oncol 122: 351-355, 1996
Schmidt CJ, Hamer DH: Cell specificity and an effect of ras on human metallothionein gene expression. Proc Natl Acad Sci USA 83: 3346-3350, 1986
Elston CW, Ellis IO: Systemic Pathology. Vol. 13 The Breast, 3rd edn. Churchill Livingstone, Edinburgh, 1998, pp 365-383
Jin R, Bay BH, Chow VTK, Tan PH, Lin VCL: Metallothionein 1E mRNA is highly expressed in estrogen receptornegative human invasive ductal breast cancer. Br J Cancer 83: 319-323, 2000
Mididoddi S, McGuirt JP, Sens MA, Todd JH, Sens DA: Isoform-specific expression of metallothionein mRNA in the developing and adult human kidney. Toxicol Lett 685: 17-27, 1996
Abdel-Mageed AB, Agrawal KC: Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Ther 4: 199-207, 1997
Jin R, Bay B, Tan P, Tan BK: Metallothionein expression and zinc levels in invasive ductal breast carcinoma. Oncol Rep 6: 871-875, 1999
Jayasurya A, Bay BH, Yap WM, Tan NG: Correlation of metallothionein expression with apoptosis in nasopharyngeal carcinoma. Br J Cancer 82: 1198-1203, 2000
Friedline JA, Garrett SH, Somji S, Todd JH, Sens DA: Differential expression of the MT-1E gene in estrogen-receptorpositive and-negative human breast cancer cell lines. Am J Pathol 152: 23-27, 1998
Fresno M, Wu W, Rodriguez JM, Nadji M: Localization of metallothionein in breast carcinomas. An immunohistochemical study. Virchows Archiv A 423: 215-219, 1993
Douglas-Jones AG, Schmid KW, Bier B, Horgan K, Lyons K, Dallimore ND, Moneypenny IJ, Jasani B: Metallothionein expression in duct carcinoma in situ of the breast. Hum Pathol 26: 217-222, 1995
Lin VCL, Ng EH, Aw SE, Tan MGK, Ng EHL, Chan VSW, Ho GH: Progestins inhibit the growth of MDA-MB-231 cells transfected with progesterone receptor complementary DNA. Clin Cancer Res 5: 395-403, 1999
Lin VCL, Ng EH, Aw SE, Tan MGK, Ng EHL, Bay BH: Progesterone induces focal adhesion in breast cancer cells MDA-MB-231 transfected with progesterone receptor cDNA. Mol Endocrinol 14: 348-358, 2000
Gilbert SF: Developmental Biology. 5th edn., Sinauer Associates, Massachusetts, 1997, pp 391-504
Schmidt CJ, Jubier MF, Hamer DH: Structure and expression of two human metallothionein-I isoform genes and a related pseudogene. J Biol Chem 260: 7731-7737, 1985
Varshney U, Jahroudi N, Foster R, Gedamu L: Structure, organization, and regulation of human metallothionein IF gene: differential and cell-type-specific expression in response to heavy metals and glucocorticoids. Mol Cell Biol 6: 26-37, 1986
Yang YY, Woo ES, Reese CE, Bahnson RR, Saijo N, Lazo JS: Human metallothionein isoform gene expression in cisplatinsensitive and resistant cells. Mol Pharmacol 45: 453-460, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jin, R., Bay, BH., Chow, V.TK. et al. Metallothionein 1F mRNA Expression Correlates with Histological Grade in Breast Carcinoma. Breast Cancer Res Treat 66, 265–272 (2001). https://doi.org/10.1023/A:1010658907462
Issue Date:
DOI: https://doi.org/10.1023/A:1010658907462